M. Alebouyeh

512 total citations
27 papers, 412 citations indexed

About

M. Alebouyeh is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, M. Alebouyeh has authored 27 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Oncology. Recurrent topics in M. Alebouyeh's work include Hemoglobinopathies and Related Disorders (4 papers), Pain Mechanisms and Treatments (3 papers) and Iron Metabolism and Disorders (3 papers). M. Alebouyeh is often cited by papers focused on Hemoglobinopathies and Related Disorders (4 papers), Pain Mechanisms and Treatments (3 papers) and Iron Metabolism and Disorders (3 papers). M. Alebouyeh collaborates with scholars based in Iran, United States and Japan. M. Alebouyeh's co-authors include Parvaneh Vossough, Hossein Rastegar, Seyed Mohammad Mousavi, Zahra Pourpak, Ehsan Ansari Dezfouli, Hossein Amini, Suparat Khamdang, Naohiko Anzai, Hitoshi Endou and Jun Inatomi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Food Chemistry and Annals of Oncology.

In The Last Decade

M. Alebouyeh

27 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Alebouyeh Iran 10 162 104 90 85 70 27 412
Daniel Chiu United States 7 125 0.8× 66 0.6× 28 0.3× 50 0.6× 62 0.9× 11 319
J.H. Poulsen Denmark 11 113 0.7× 15 0.1× 41 0.5× 41 0.5× 42 0.6× 19 439
Rajat Singh United States 11 206 1.3× 31 0.3× 50 0.6× 12 0.1× 12 0.2× 17 514
Anne‐Cathrine S. Vogt Switzerland 8 140 0.9× 34 0.3× 35 0.4× 95 1.1× 8 0.1× 16 447
Isabel Huber‐Ruano Spain 11 166 1.0× 28 0.3× 110 1.2× 17 0.2× 35 0.5× 15 401
Patrice K. Held United States 13 415 2.6× 34 0.3× 25 0.3× 43 0.5× 65 0.9× 31 632
Shakuntala Chaube United States 13 187 1.2× 41 0.4× 31 0.3× 35 0.4× 103 1.5× 23 550
Hongli Zhu China 12 194 1.2× 7 0.1× 53 0.6× 33 0.4× 16 0.2× 48 423
Thomas C. Thomas United States 8 111 0.7× 42 0.4× 19 0.2× 81 1.0× 7 0.1× 11 459
Leonard Angka Canada 10 142 0.9× 12 0.1× 153 1.7× 54 0.6× 9 0.1× 16 615

Countries citing papers authored by M. Alebouyeh

Since Specialization
Citations

This map shows the geographic impact of M. Alebouyeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Alebouyeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Alebouyeh more than expected).

Fields of papers citing papers by M. Alebouyeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Alebouyeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Alebouyeh. The network helps show where M. Alebouyeh may publish in the future.

Co-authorship network of co-authors of M. Alebouyeh

This figure shows the co-authorship network connecting the top 25 collaborators of M. Alebouyeh. A scholar is included among the top collaborators of M. Alebouyeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Alebouyeh. M. Alebouyeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashemi‐Najafabadi, Sameereh, et al.. (2018). Determination of Biological Activity of Recombinant Reteplase Using Clot Lysis Time and Activated Partial Thromboplastin Time (APTT) Lysis Methods: A Comparative Study.. PubMed. 17(4). 1503–1508. 2 indexed citations
2.
Alebouyeh, M., et al.. (2016). Rapid formulation assessment of filgrastim therapeutics by a thermal stress test. Biologicals. 44(3). 150–156. 4 indexed citations
3.
Khaki, Arash, et al.. (2016). Attenuated Lead Induced Apoptosis in Rat Hepatocytes in the Presence of Lycopersicon Esculentum.. PubMed. 54(4). 240–4. 2 indexed citations
4.
Alebouyeh, M., et al.. (2015). Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines. Asian Pacific Journal of Cancer Prevention. 16(14). 5977–5981. 22 indexed citations
5.
Mousavi, Seyed Mohammad, et al.. (2015). Halal authenticity of gelatin using species-specific PCR. Food Chemistry. 184. 203–206. 78 indexed citations
6.
Shekarchi, Maryam, et al.. (2015). Development and Validation of a Micellar Capillary Electrophoresis Method for Determination of IFNβ-1b in Lyophilized Formulation of a Biosimilar Product.. PubMed. 14(3). 747–55. 3 indexed citations
7.
Mousavi, Seyed Mohammad, et al.. (2014). Detection of Chicken Meat Adulteration in Raw Hamburger Using Polymerase Chain Reaction. 1(2). 36–40. 18 indexed citations
8.
Alebouyeh, M. & Hossein Amini. (2014). Rapid determination of lamivudine in human plasma by high-performance liquid chromatography. Journal of Chromatography B. 975. 40–44. 14 indexed citations
9.
Alebouyeh, M., et al.. (2008). Hodgkin Lymphoma as Second Malignancy during Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia. Klinische Pädiatrie. 220(6). 388–390. 1 indexed citations
10.
Shamshirsaz, Alireza A., Mir Reza Bekheirnia, Mohammad Kamgar, et al.. (2007). BONE MINERAL DENSITY IN IRANIAN ADOLESCENTS AND YOUNG ADULTS WITH β-THALASSEMIA MAJOR. Pediatric Hematology and Oncology. 24(7). 469–479. 28 indexed citations
11.
Alebouyeh, M., et al.. (2005). Successful ambulatory treatment of Hodgkin's disease in Iranian children based on German-Austrian DAL-HD 85-90: single institutional results. Annals of Oncology. 16(12). 1936–1940. 8 indexed citations
12.
Alebouyeh, M., et al.. (2004). Hydroxyurea in the treatment of major �-thalassemia and importance of genetic screening. Annals of Hematology. 83(7). 430–433. 63 indexed citations
13.
Pourpak, Zahra, Abolhasan Ahmadiani, & M. Alebouyeh. (2004). Involvement of Interleukin‐1β in Systemic Morphine Effects on Paw Oedema in a Mouse Model of Acute Inflammation. Scandinavian Journal of Immunology. 59(3). 273–277. 16 indexed citations
14.
Alebouyeh, M., Michio Takeda, Maristela L. Onozato, et al.. (2003). Expression of Human Organic Anion Transporters in the Choroid Plexus and Their Interactions With Neurotransmitter Metabolites. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Alebouyeh, M., Michio Takeda, Maristela L. Onozato, et al.. (2003). Expression of Human Organic Anion Transporters in the Choroid Plexus and Their Interactions With Neurotransmitter Metabolites. Journal of Pharmacological Sciences. 93(4). 430–436. 79 indexed citations
16.
Alebouyeh, M., Zahra Pourpak, & Abolhassan Ahmadiani. (2002). INCREASE IN SERUM LEVEL OF INTERLEUKIN-1 ALPHA MEDIATES MORPHINE ANTI-INFLAMMATORY EFFECT IN CARRAGEENAN-INDUCED PAW OEDEMA IN MICE. Cytokine. 19(2). 102–105. 13 indexed citations
17.
Alebouyeh, M. & Parvaneh Vossough. (1993). Hodgkin disease in Iranian children. European Journal of Pediatrics. 152(1). 21–23. 8 indexed citations
18.
Alebouyeh, M., et al.. (1984). Vergleichende Untersuchung der Durchseuchung mit Epstein Barr-Virusinfektionen im Iran und in Deutschland. Monatsschrift Kinderheilkunde. 132(11). 850–851. 4 indexed citations
19.
Alebouyeh, M., et al.. (1977). Hypertriglyceridemia in homozygous beta-thalassemia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 32(1). 83–6. 1 indexed citations
20.
Alebouyeh, M., et al.. (1974). The activity of platelet factor 4 in plasma of healthy and high risk newborns. European Journal of Pediatrics. 116(2). 137–142. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026